 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

---
- Morgan Stanley reduced its position in Constellation Pharmaceuticals, Inc. (NASDAQ:CNST)
  by 1.2% during the first quarter, HoldingsChannel reports. The fund owned 1,211,640
  shares of the companys stock after selling 14,215 shares during the quarter. Morgan
  Stanleys holdings in ...


Morgan Stanley Sells 14,215 Shares of Constellation Pharmaceuticals, Inc. (NASDAQ:CNST)

---
- Jane Street Group LLC grew its holdings in shares of Constellation Pharmaceuticals,
  Inc. (NASDAQ:CNST) by 14.9% during the 1st quarter, HoldingsChannel reports. The
  fund owned 12,046 shares of the companys stock after acquiring an additional 1,561
  shares during the quarter. Jane Street Group ...


Jane Street Group LLC Raises Stake in Constellation Pharmaceuticals, Inc. (NASDAQ:CNST)

---
- 'When MorphoSys AG acquired oncology firm Constellation Pharmaceuticals Inc. for
  $1.7 billion, it instantly doubled its Boston-area headcount. MorphoSys (Nasdaq:
  MOR) had already established a U.S. headquarters in Boston back in 2019. By this
  summer, the office had grown to about 150 people, including sales associates who
  travel around the U.S.'


After acquiring local oncology firm, MorphoSys plans to grow in Boston

---
- Over the last three days, A.I.dvisor has detected that CNST's AroonUp green line
  (see chart) is above 70, while the AroonDown red line is below 30. When the green
  line goes above 70 while the red line stays below 30, this is an indicator that
  the stock could be poised for a strong Uptrend. For ...


Constellation Pharmaceuticals (CNST, $33.99) Aroon Indicator entered an Uptrend on July 16, 2021.

Constellation Pharmaceuticals (CNST, $33.99) Aroon Indicator entered an Uptrend on July 15, 2021.

---
- MorphoSys AG (MOR) announced the completion of the previously-announced cash tender
  offer for all outstanding shares of Constellation Pharmaceuticals (CNST) which is
  in a deal to...


MorphoSys at a historic low as it completes acquisition of Constellation Pharma

Constellation Pharmaceuticals (CNST, $33.99) Aroon Indicator entered an Uptrend on July 14, 2021.

---
- Company Announces Successful Completion of Tender Offer Moves Forward with Strategic
  Funding Partnership with Royalty PharmaPLANEGG / MUNICH, GERMANY / ACCESSWIRE /
  July 15, 2021 / MorphoSys AG (FSE:MOR; NASDAQ:MOR) ("MorphoSys") today announced
  the successful completion of its...


MorphoSys to Complete Transformational Acquisition of Constellation Pharmaceuticals, Bolstering Its Position in Hematology-Oncology

Constellation Pharmaceuticals (CNST, $33.97) Aroon Indicator entered an Uptrend on July 13, 2021.

---
- We know that hedge funds generate strong, risk-adjusted returns over the long run,
  therefore imitating the picks that they are collectively bullish on can be a profitable
  strategy for retail investors. With billions of dollars in assets, smart money investors
  have to conduct complex analyses, spend...


Should I Avoid Constellation Pharmaceuticals, Inc. (CNST)?

Constellation Pharmaceuticals is the first biopharmaceutical company dedicated to the development of novel therapeutics in the emerging field of Epigenetics, a new field of science which is focused on selective regulators of epigenetic function, which are critical to controlling gene expression.

Watchers	888
52-Wk Low	$17.00
52-Wk High	$39.30

Market Cap	$1.63B
Volume (M)	1.31M
52-Wk High	$39.30
52-Wk Low	$17.00

CNST Constellation Pharmaceuticals, Inc.

About

Feed

News

Fundamentals